MidCap T ApS: Financial statements 2022
CVR: 40238581
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
MidCap T ApS (CVR 40238581) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -13,000 and a net result of DKK -11,000 compared with DKK -35,000 the year before. Equity in the 2022 report amounted to DKK 119,310,000. The solvency ratio was 99.6%.
- Gross Profit
- DKK -13,000
- Profit/Loss
- DKK -11,000
- Equity
- DKK 119,310,000
- Total Assets
- DKK 119,760,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -13 t. | -11 t. | 119.3 mio. | - |
| 2021 | - | -19 t. | -35 t. | 119.3 mio. | - |
| 2020 | - | -158 t. | -32.2 mio. | 119.4 mio. | - |
| 2019 | - | -10 t. | -8 t. | 150.1 mio. | - |
Official annual report
Keep an eye on MidCap T ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
MidCap T ApS has published its annual report for 2021. Gross profit came to DKK -19,000, and the net result was DKK -35,000.
About MidCap T ApS
MidCap T ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2019. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Martin Jørgensen. The board consists of Ulrik Kronborg Markussen (chair), Claus Svane Gleerup, Mads Bødtcher-Hansen and Martin Jørgensen. The company's owners include ORIFARM GENERICS HOLDING A/S, MBH ApS and Janus Investering ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -16,000 and a net result of DKK -24,871,000 compared with DKK 621,000 the year before. Equity in the 2025 report amounted to DKK 173,650,000.